Galectin Therapeutics (GALT) EBIT Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,386.07% |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | 48.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.37% |
| Dec 31, 2025 | 72.92% |
| Sep 30, 2025 | 53.70% |
| Jun 30, 2025 | 59.04% |
| Mar 31, 2025 | 18.15% |
| Dec 31, 2024 | -29.99% |
| Sep 30, 2024 | 1.09% |
| Jun 30, 2024 | -25.41% |
| Mar 31, 2024 | 6.71% |
| Dec 31, 2023 | 10.08% |
| Sep 30, 2023 | -12.85% |
| Jun 30, 2023 | 6.82% |
| Mar 31, 2023 | -4.10% |
| Dec 31, 2022 | -43.21% |
| Sep 30, 2022 | 1.48% |
| Jun 30, 2022 | -17.93% |
| Mar 31, 2022 | -57.27% |
| Dec 31, 2021 | 5.20% |
| Sep 30, 2021 | -39.12% |
| Jun 30, 2021 | -34.27% |
| Mar 31, 2021 | -76.26% |
| Dec 31, 2020 | -50.96% |
| Sep 30, 2020 | -106.99% |
| Jun 30, 2020 | -102.05% |
| Mar 31, 2020 | -51.42% |
| Dec 31, 2019 | -73.80% |
| Sep 30, 2019 | -6.83% |
| Jun 30, 2019 | 19.66% |
| Mar 31, 2019 | 43.35% |
| Dec 31, 2018 | -25.79% |
| Sep 30, 2018 | 39.28% |
| Jun 30, 2018 | 16.73% |
| Mar 31, 2018 | 15.53% |
| Dec 31, 2017 | 48.40% |
| Sep 30, 2017 | 2.71% |
| Jun 30, 2017 | 18.39% |
| Mar 31, 2017 | 27.41% |
| Dec 31, 2016 | 1.79% |
| Sep 30, 2016 | 23.09% |
| Jun 30, 2016 | -18.77% |
| Mar 31, 2016 | -40.79% |
| Dec 31, 2015 | -25.42% |
| Sep 30, 2015 | -69.66% |
| Jun 30, 2015 | -37.99% |
| Mar 31, 2015 | 0.08% |
| Dec 31, 2014 | -33.17% |
| Sep 30, 2014 | 1.92% |
| Jun 30, 2014 | -32.51% |
| Mar 31, 2014 | -51.00% |
| Dec 31, 2013 | -17.72% |
| Sep 30, 2013 | -22.41% |
| Jun 30, 2013 | 4.54% |
| Mar 31, 2013 | -64.26% |
| Dec 31, 2012 | 29.36% |
| Sep 30, 2012 | -42.45% |
| Jun 30, 2012 | 10.80% |
| Mar 31, 2012 | 2.98% |
| Dec 31, 2011 | -161.60% |
| Sep 30, 2011 | -67.74% |
| Jun 30, 2011 | -121.56% |